[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Stock Master Flash [@StckMasterFlash](/creator/twitter/StckMasterFlash) on x 2902 followers Created: 2025-07-23 21:04:45 UTC In a market projected to grow to nearly half a billion dollars by 2035, @thiogenesis is dosing patients in its EU Phase X trial for TTI‑0102, targeting the underlying antioxidant deficiencies in MELAS. Interim efficacy readout expected this fall. More Info🔽 $TTI.v $TTIPF Source:  XX engagements  **Related Topics** [$tti](/topic/$tti) [$ttipf](/topic/$ttipf) [$ttiv](/topic/$ttiv) [more info](/topic/more-info) [Post Link](https://x.com/StckMasterFlash/status/1948127165847138686)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Stock Master Flash @StckMasterFlash on x 2902 followers
Created: 2025-07-23 21:04:45 UTC
In a market projected to grow to nearly half a billion dollars by 2035, @thiogenesis is dosing patients in its EU Phase X trial for TTI‑0102, targeting the underlying antioxidant deficiencies in MELAS.
Interim efficacy readout expected this fall.
More Info🔽 $TTI.v $TTIPF
Source:
XX engagements
/post/tweet::1948127165847138686